The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 27, No. 9, pp. 1126-1133.
© 1993 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sacristan, J.
Right arrow Articles by Galende, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sacristan, J.
Right arrow Articles by Galende, I


Research Articles

Evaluation of pharmacoeconomic studies: utilization of a checklist

JA Sacristan, J Soto, and I Galende

OBJECTIVE: To review the fundamental concepts used in clinical economic analysis and establish a simple model to systematically evaluate the quality of pharmacoeconomic studies. DATA SOURCES: A MEDLINE search was used to identify pertinent pharmacoeconomic literature, including reviews. STUDY SELECTION: Selected literature evaluating the methodology of health economics studies was used. CONCLUSIONS: The number of studies presenting a pharmacoeconomic evaluation has increased progressively; however, the quality of the studies has not improved in parallel. The existence of different types of pharmacoeconomic studies does not justify their arbitrary use and the achievement of valid conclusions must be based on sound knowledge of the concepts employed, as well as on use of the most adequate tool in each instance. By evaluating pharmacoeconomic studies systematically, the more common errors (i.e., in planning the study or interpreting the results) can be detected and thus prevented. The checklist we present has 12 sections, each of which includes several subsections. After evaluating the corresponding subsections, each section is labeled as "correct," "acceptable," "doubtful," "incorrect," or "not applicable." From this qualitative evaluation, aspects that have been dealt with correctly and those needing improvement will become apparent. Also, the checklist permits the user to verify whether the results have been correctly obtained and, therefore, whether the conclusions are valid. The use of a checklist for evaluating pharmacoeconomic studies may be useful for researchers, journal editors, and the audience when performing, receiving, reading, or accepting a clinical economic study.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
M. Machado, M. Iskedjian, and T. R Einarson
Quality Assessment of Published Health Economic Analyses from South America
Ann. Pharmacother., May 1, 2006; 40(5): 943 - 949.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
J. A. Johnson and S. J. Coons
Evaluation of Published Pharmacoeconomic Studies
Journal of Pharmacy Practice, August 1, 1995; 8(4): 156 - 166.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1993 by Harvey Whitney Books Company.